The forgotten time Ruth Bader Ginsburg fought against forced sterilization
By Ria Tabacco Mar,
The Washington Post
| 09. 19. 2020
The words of the nurse, Dawn Wooten, made me recall another uterus collector, from another time, and another woman who fought back.
Apart from her legendary dissents on the Supreme Court of the United States, Ginsburg is perhaps best known for the six cases she argued before the court as director of the ACLU Women’s Rights Project, a position I’m privileged to hold now. In 1973, the year Ginsburg had her first argument before the high court, she and the Women’s Rights Project co-founder, Brenda Feigen, filed a federal lawsuit in North Carolina on behalf of Nial Ruth Cox, a Black...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...